1.
Stadler R, Luger T, Bieber T, Köhler U, Linse R, Technau K, et al. Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial. AO [Internet]. 2006 Jan. 1 [cited 2025 Feb. 17];45(4):389-9. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/27459